About
Biotech executive with 20+ years focused on oncology and diagnostics, most recently Chief Clinical Officer of Agendia. Co-founder of ThromboDx, Qameleon Therapeutics and Oncosence. Joined XGEN in 2023.
Experience
- Scope Biosciences B.V.Chief Executive Officercurrent2026 — presentWageningen, Gelderland, Netherlands
- Lixte Biotechnology Holdings, Inc.Chief Technology Officercurrent2025 — present
- Lixte Biotechnology Holdings, Inc.Chief Executive Officer2023 — 2025Amsterdam, North Holland, Netherlands
- Lixte Biotechnology Holdings, Inc.Board Member2022 — 2025Pasadena, California, United States
- XGEN Venture SGR S.p.A.Venture Partnercurrent2023 — presentMilan, Lombardy, Italy
- Tethis S.p.ABoard Membercurrent2021 — presentMilan, Lombardy, Italy
- Agendia, Inc.Chief Clinical and BD Officer2012 — 2023Irvine California / Amsterdam The Netherlands
- Agendia, Inc.VP Marketing and Sales2008 — 2012Amsterdam, Netherlands / Irvine, CA
- Agendia, Inc.Director Business Development2004 — 2008The Randstad, Netherlands
- Qameleon TherapeuticsCo-Founder2015 — 2023The Randstad, Netherlands
- thromboDxCo-Founder2012 — 2016The Randstad, Netherlands
- Amsterdam Economic BoardBoard Member2009 — 2013The Randstad, Netherlands
- KreatechBusiness Development Manager2002 — 2003The Randstad, Netherlands
- Unilever │ICI│UnichemaSales Manager Mid Europe2000 — 2002Emmerich, Germany
- Unilever │ICI│UnichemaSales Manager Benelux Scandinavia1998 — 2000Gouda, Netherlands
- Unilever │ICI│UnichemaIndustrial Marketing Management Trainee1997 — 1998Kuala Lumpur, Malaysia / Gouda Netherlands
Skills & more
Regulatory ApprovalsMolecular DiagnosticsHealthcare ReimbursementPublic Equity OfferingsInvestor RelationsVenture CapitalNASDAQU.S. SEC FilingsBiotechnology25Lifesciences14Oncology17Business Development14
+12 more
CancerClinical TrialsPharmaceutical IndustryGenomicsStrategyMedical DevicesLife SciencesMolecular BiologyCommercializationProduct LaunchManagementGeneticsLanguages Dutch · English · German
From Bastiaan's professional profile.
Colleagues at XGEN Venture
Bertil Lindmark
Venture Partner at XGEN Venture
Bianca Benatti
Jr. Analyst at XGEN Venture
Carlotta Marchese
Regulatory and Corporate Affairs Specialist at XGEN Venture
Daniele Scarinci
Founder and Managing Partner at XGEN Venture
Federica Draghi
Founder and Managing Partner at XGEN Venture
Gokhan Batur
Venture Partner at XGEN Venture
Graziano Piredda
Sr. Analyst at XGEN Venture
Keith Dawkins
Venture Partner at XGEN Venture
Frequently asked questions
- Who is Bastiaan van der Baan?
- Biotech executive with 20+ years focused on oncology and diagnostics, most recently Chief Clinical Officer of Agendia. Co-founder of ThromboDx, Qameleon Therapeutics and Oncosence. Joined XGEN in 2023.
- Where does Bastiaan van der Baan work?
- Bastiaan van der Baan is Venture Partner at XGEN Venture.
- Where did Bastiaan van der Baan go to school?
- Bastiaan van der Baan studied at Wageningen University & Research (MSc, Molecular Sciences); NIMA, Nederlands Instituut voor Marketing (NIMA A & B); Murmellius Gymnasium.
Same school
Also attended Wageningen University & Research22
Xavier MesnierPartner, Head of Frontiers in Health & Bio Investments at Verve VenturesThomas van den BoezemPartner at PeakBridge VCLaura ArgelichAssociate at Ysios CapitalPavlos KalaitzoglouDirector of Research at Astanor VenturesMarcel ZijpSenior Investment Manager at Brightlands Venture PartnersLauri ReuterPartner at Nordic Foodtech VC
+ 16 more
Also attended NIMA, Nederlands Instituut voor Marketing2
Shared employers
Also worked at Agendia, Inc.2
Also worked at Amsterdam Economic Board2
Also worked at Unilever │ICI│Unichema159
Julian LuttermanInvestor at DN CapitalGizem CakilInvestor at OpenView Venture PartnersStacey HeroInvestor at Third Rock VenturesAshu GargInvestor at Foundation CapitalJoanna Skoler GilmanChief Marketing and Communications Officer at .406 VenturesPetra MeyerInvestor at Golden Seeds
+ 153 more